Please wait while we open this resource.
K
Guidelines & protocols
AMERICAN SOCIETY OF HEMATOLOGY 2026 GUIDELINES FOR IMMUNE THROMBOCYTOPENIA (ITP): INITIAL AND SECOND-LINE THERAPY IN ADULTS WITH PRIMARY ITP
Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States
PDF202662 pages1.9 MB
The guidelines provide updated recommendations based on new clinical trials and treatments available since the previous 2019 guidelines. They emphasize an individualized approach to therapy selection, incorporating patient values and treatment availability. The document also discusses the efficacy of combination therapies and their impact on patient quality of life, as well as considerations for specific patient populations.
No account needed
Ask this resource
Answers use this document only.
More like this
Resources from the same specialty and type. Curated links will replace these when added.
Clinical Resources
Documents that extend or complement this resource.
SICKLECELL GUIDELINES 2025 (2)
Same clinical topic · Hematology
AMERICAN SOCIETY OF HEMATOLOGY 2026 GUIDELINES FOR DIAGNOSIS OF IRON DEFICIENCY
Same clinical topic · Hematology
Guideline for SCD Management - Uganda (2)
Same clinical topic · Hematology
SICKLECELL GUIDELINES 2025-2030
Same clinical topic · Hematology
MANAGEMENT OF TRANSFUSION DEPENDENT THALASSAEMIA (TDT)
Same clinical topic · Hematology
AMERICAN SOCIETY OF HEMATOLOGY 2026 GUIDELINES FOR IMMUNE THROMBOCYTOPENIA (ITP): INITIAL AND SECOND-LINE THERAPY IN ADULTS WITH PRIMARY ITP
Same clinical topic · Hematology
AMERICAN SOCIETY OF HEMATOLOGY 2021 GUIDELINES FOR SICKLE CELL DISEASE: STEM CELL TRANSPLANTATION
Same clinical topic · Hematology
GUIDELINES FOR THE MANAGEMENT OF EMERGENCIES AND CRITICAL ILLNESS IN PEDIATRIC AND ADULT PATIENTS WITH SICKLE CELL DISEASE
Same clinical topic · Hematology
AMERICAN SOCIETY OF HEMATOLOGY 2021 GUIDELINES FOR MANAGEMENT OF VENOUS THROMBOEMBOLISM: PREVENTION AND TREATMENT IN PATIENTS WITH CANCER
Same clinical topic · Hematology